Mutation spectrum and clinical investigation of achromatopsia patients with mutations in the GNAT2 gene

Julia Felden, Britta Baumann, Manir Ali, Isabelle Audo, Carmen Ayuso, Beatrice Bocquet, Ingele Casteels, Blanca Garcia-Sandoval, Samuel G Jacobson, Bernhard Jurklies, Ulrich Kellner, Line Kessel, Birgit Lorenz, Martin McKibbin, Isabelle Meunier, Thomy de Ravel, Thomas Rosenberg, Klaus Rüther, Maria Vadala, Bernd WissingerKatarina Stingl, Susanne Kohl

6 Citations (Scopus)

Abstract

Achromatopsia (ACHM) is a hereditary cone photoreceptor disorder characterized by the inability to discriminate colors, nystagmus, photophobia, and low-visual acuity. Six genes have been associated with this rare autosomal recessively inherited disease, including the GNAT2 gene encoding the catalytic α-subunit of the G-protein transducin which is expressed in the cone photoreceptor outer segment. Out of a cohort of 1,116 independent families diagnosed with a primary clinical diagnosis of ACHM, we identified 23 patients with ACHM from 19 independent families with likely causative mutations in GNAT2, representing 1.7% of our large ACHM cohort. In total 22 different potentially disease-causing variants, of which 12 are novel, were identified. The mutation spectrum also includes a novel copy number variation, a heterozygous duplication of exon 4, of which the breakpoint matches exactly that of the previously reported exon 4 deletion. Two patients carry just a single heterozygous variant. In addition to our previous study on GNAT2-ACHM, we also present detailed clinical data of these patients.

Original languageEnglish
JournalHuman Mutation
Volume40
Issue number8
Pages (from-to)1145-1155
Number of pages11
ISSN1059-7794
DOIs
Publication statusPublished - 2019

Fingerprint

Dive into the research topics of 'Mutation spectrum and clinical investigation of achromatopsia patients with mutations in the GNAT2 gene'. Together they form a unique fingerprint.

Cite this